Russell Investments Group Ltd. Increases Holdings in Encompass Health Co. (NYSE:EHC)

Russell Investments Group Ltd. grew its holdings in shares of Encompass Health Co. (NYSE:EHC) by 1.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 101,363 shares of the company’s stock after purchasing an additional 1,927 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.10% of Encompass Health worth $7,661,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in EHC. Berman Capital Advisors LLC increased its holdings in Encompass Health by 75.1% in the 2nd quarter. Berman Capital Advisors LLC now owns 788 shares of the company’s stock worth $61,000 after acquiring an additional 338 shares during the last quarter. Maverick Capital Ltd. purchased a new stake in Encompass Health in the 2nd quarter worth about $73,000. Rockefeller Capital Management L.P. increased its holdings in Encompass Health by 377.1% in the 2nd quarter. Rockefeller Capital Management L.P. now owns 1,002 shares of the company’s stock worth $77,000 after acquiring an additional 792 shares during the last quarter. Private Capital Group LLC increased its holdings in Encompass Health by 23.4% in the 3rd quarter. Private Capital Group LLC now owns 1,308 shares of the company’s stock worth $99,000 after acquiring an additional 248 shares during the last quarter. Finally, Fifth Third Bancorp increased its holdings in Encompass Health by 265.2% in the 3rd quarter. Fifth Third Bancorp now owns 1,366 shares of the company’s stock worth $103,000 after acquiring an additional 992 shares during the last quarter. 90.21% of the stock is owned by institutional investors.

EHC has been the subject of several recent research reports. Mizuho decreased their price objective on Encompass Health from $94.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, November 3rd. TheStreet downgraded Encompass Health from a “b-” rating to a “c+” rating in a research note on Monday, November 15th. BMO Capital Markets cut their target price on Encompass Health from $102.00 to $75.00 and set an “outperform” rating for the company in a research note on Monday, November 1st. Truist cut their target price on Encompass Health from $100.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 13th. Finally, UBS Group assumed coverage on Encompass Health in a research note on Thursday, September 23rd. They issued a “buy” rating and a $98.00 target price for the company. One research analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Encompass Health has an average rating of “Buy” and an average price target of $88.30.

Shares of EHC opened at $65.86 on Friday. The company has a market cap of $6.55 billion, a PE ratio of 16.22, a price-to-earnings-growth ratio of 0.74 and a beta of 1.02. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 1.39. The stock has a 50-day moving average price of $64.69 and a 200-day moving average price of $64.58. Encompass Health Co. has a 12-month low of $56.31 and a 12-month high of $89.68.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Wednesday, October 27th. The company reported $1.03 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.06 by ($0.03). The business had revenue of $1.28 billion for the quarter, compared to the consensus estimate of $1.31 billion. Encompass Health had a net margin of 8.10% and a return on equity of 19.87%. The business’s revenue was up 9.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.78 EPS. As a group, analysts predict that Encompass Health Co. will post 4.31 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 18th. Investors of record on Monday, January 3rd will be given a $0.28 dividend. The ex-dividend date of this dividend is Friday, December 31st. This represents a $1.12 dividend on an annualized basis and a yield of 1.70%. Encompass Health’s payout ratio is 27.59%.

Encompass Health Profile

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.

Recommended Story: Book Value Per Share – BVPS

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.